GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI. [electronic resource]
Producer: 20121203Description: 683-90 p. digitalISSN:- 1473-5741
- Amyloid Precursor Protein Secretases -- antagonists & inhibitors
- Antineoplastic Agents -- therapeutic use
- Basic Helix-Loop-Helix Transcription Factors -- drug effects
- Benzodiazepinones -- therapeutic use
- Calcium-Binding Proteins -- drug effects
- Carbamates -- therapeutic use
- Carcinoma, Hepatocellular -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival
- Dipeptides -- therapeutic use
- Gene Expression Regulation, Neoplastic -- drug effects
- Genes, myc -- drug effects
- Hep G2 Cells
- Homeodomain Proteins -- drug effects
- Humans
- Intercellular Signaling Peptides and Proteins -- genetics
- Jagged-1 Protein
- Liver Neoplasms -- drug therapy
- Membrane Proteins -- drug effects
- Oligopeptides -- therapeutic use
- Receptors, Notch -- antagonists & inhibitors
- Serrate-Jagged Proteins
- Transcription Factor HES-1
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.